FDA CVM Update on Jerky Treats

January 9, 2013

The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) released today a progress report on its investigation into reports of illnesses and deaths associated with jerky pet treats from China. The report includes a summary of adverse event reports received by FDA through August 2012, Establishment Inspection Reports from FDA’s inspection of two chicken jerky manufacturing plants in China, and details about FDA’s ongoing investigation.

FDA is in communication with the New York State Department of Agriculture and Markets (NYSDAM) regarding its finding of antibiotic residues in chicken jerky treats from China. Correspondingly, Del Monte, the company that makes Milo’s Kitchen Chicken Jerky Treats and Chicken Grillers, and Nestle-Purina, the makers of Waggin’ Train and Canyon Creek Ranch dog treats have both initiated a nationwide removal of these products from the market.

Based on the FDA’s review of the NYSDAM results, there is no evidence that raises health concerns, and these results are highly unlikely to be related to the reports of illnesses FDA has received related to jerky pet treats. FDA commends Del Monte and Nestle-Purina for withdrawing these products from the market in response to this product quality issue. FDA also welcomes additional information about NYSDAM’s testing methodology, which is different and reportedly more sensitive than currently validated and approved regulatory methods.

FDA reminds pet owners that jerky pet treats are not necessary for pets to have a fully balanced diet, so eliminating them will not harm pets. Commercially produced pet food, which is very safe, contains all of the nutrients that pets need.